Biomoda Updates New Mexico Legislature on Screening Program for New Mexico Veterans

ALBUQUERQUE, N.M., Sept. 21, 2009 (GLOBE NEWSWIRE) -- In an update to New Mexico
state legislators, Biomoda, Inc. (OTCBB:BMOD) President John Cousins reported
that the state-funded lung cancer screening program for military veterans has
recruited 500 participants, completed the screening process on 130 participants
and is proceeding on schedule with an ancillary benefit.

"Our focus, of course, is early detection of asymptomatic lung cancer; however,
as a result of the comprehensive protocol for this study we have also detected
potentially life-threatening conditions, including emphysema, pneumonia and
coronary artery disease, in approximately 80 percent of our participants and
referred them to follow-on medical care," Cousins said.

The Legislature has appropriated $1.65 million to date to screen New Mexico
veterans for early-stage lung cancer using Biomoda's proprietary diagnostic.
Testifying before the Military and Veterans' Affairs Committee of the New Mexico
State Legislature, Cousins said that Biomoda expects the pilot program to
identify five to ten individuals with early-stage lung cancer by the end 2009.

Biomoda is conducting the screening study in collaboration with the New Mexico
Department of Veterans Services (NMDVS) and the New Mexico Institute of Mining
and Technology (NM Tech).

Under the guidance of a respiratory therapist, study volunteers provide a
deep-lung sputum sample to be processed with Biomoda's patented CyPath(R) assay
in the Biomoda lab. Biomoda's CyPath(R) results are compared to a CT scan and a
traditional cytopathology analysis of the sputum sample to confirm accuracy.
CyPath(R) is based on a process utilizing a molecular marker, originally
developed at Los Alamos National Laboratory that preferentially binds to cancer
cells and fluoresces red under ultraviolet light.

For more information on Biomoda, visit the website at www.biomoda.com. Follow
news about Biomoda on Facebook and Twitter.

-0-
CONTACT: Biomoda, Inc.
John Cousins
505.821.0875